174 related articles for article (PubMed ID: 7297433)
1. [Effects of magaldrate on circadian profile of gastric juice pH in medical intensive care patients (author's transl)].
Dammann HG; Flashoff D; Müller P; Kather H; Simon B
Dtsch Med Wochenschr; 1981 Oct; 106(44):1457-8. PubMed ID: 7297433
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two antacid preparations on intragastric acidity--a two-centre open randomised cross-over placebo-controlled trial.
Sulz MC; Manz M; Grob P; Meier R; Drewe J; Beglinger C
Digestion; 2007; 75(2-3):69-73. PubMed ID: 17496418
[TBL] [Abstract][Full Text] [Related]
3. Effect of aluminum hydroxide/magnesium hydroxide antacid and bismuth subsalicylate on gastric pH in horses.
Clark CK; Merritt AM; Burrow JA; Steible CK
J Am Vet Med Assoc; 1996 May; 208(10):1687-91. PubMed ID: 8641951
[TBL] [Abstract][Full Text] [Related]
4. [Neutralizing capacity, pepsin inactivation and binding to bile acids and lysolecithin of the antacid magaldrate (author's transl)].
Baur C; Becker A; Linder R; Schwan T
Arzneimittelforschung; 1981; 31(3):504-7. PubMed ID: 6784737
[TBL] [Abstract][Full Text] [Related]
5. [Antacids--gel or tablet. A randomized, double-blind, placebo-controlled study].
Schulthess HK; Häcki WH
Schweiz Med Wochenschr; 1985 Jul; 115(29):1016-9. PubMed ID: 4048899
[TBL] [Abstract][Full Text] [Related]
6. Cytoprotective and antiulcer activities of the antacid magaldrate in the rat.
Borella LE; DiJoseph JF; Mir GN
Arzneimittelforschung; 1989 Jul; 39(7):786-9. PubMed ID: 2783181
[TBL] [Abstract][Full Text] [Related]
7. Assessment of antacid characteristics of drugs containing a combination of aluminium and magnesium salts using the "artificial stomach" model.
Vatier J; Vitre MT; Lionnet F; Poitevin C; Mignon M
Arzneimittelforschung; 1990 Jan; 40(1):42-8. PubMed ID: 2339999
[TBL] [Abstract][Full Text] [Related]
8. Effect of Rennie Liquid versus Maalox Liquid on intragastric pH in a double-blind, randomized, placebo-controlled, triple cross-over study in healthy volunteers.
Hürlimann S; Michel K; Inauen W; Halter F
Am J Gastroenterol; 1996 Jun; 91(6):1173-80. PubMed ID: 8651166
[TBL] [Abstract][Full Text] [Related]
9. Effect of proteolytic enzymes and polypeptides on the antacid activity of almagate and other antacids.
Beneyto JE; Fábregas JL
Arzneimittelforschung; 1984; 34(10A):1357-60. PubMed ID: 6391496
[TBL] [Abstract][Full Text] [Related]
10. A comparative assessment of a new antacid formulation based on magaldrate.
McCafferty DF; Woolfson AD
J Clin Hosp Pharm; 1983 Dec; 8(4):349-55. PubMed ID: 6662972
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antacid tablets and liquid in fasting and fed men and women.
Thomson AB; Pinchbeck B; Kirdeikis J; Kirdeikis P; Zuk L; Brunet MK; Jurima-Romet M; Murray PE
Clin Ther; 1988; 10(2):158-68. PubMed ID: 3273863
[TBL] [Abstract][Full Text] [Related]
12. [Testing of a new antacid with the Heidelberger capsule in healthy persons (author's transl)].
Aenishänslin HW; Stalder GA
Schweiz Rundsch Med Prax; 1975 Jul; 64(26):843-6. PubMed ID: 238192
[No Abstract] [Full Text] [Related]
13. Antacid and formula effects on gastric acidity in infants with gastroesophageal reflux.
Sutphen JL; Dillard VL; Pipan ME
Pediatrics; 1986 Jul; 78(1):55-7. PubMed ID: 3725503
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a new antacid, almagate.
Beneyto JE; Fábregas JL; Moragues J; Spickett RG
Arzneimittelforschung; 1984; 34(10A):1350-4. PubMed ID: 6439224
[TBL] [Abstract][Full Text] [Related]
15. Magaldrate stimulates endogenous prostaglandin E2 synthesis in human gastric mucosa in vitro and in vivo.
Schmidt C; Baumeister B; Kipnowski J; Miederer SE; Vetter H
Hepatogastroenterology; 1998; 45(24):2443-6. PubMed ID: 9951941
[TBL] [Abstract][Full Text] [Related]
16. [Determination of neutralization capacity of antacids in gastric juice].
Halter F
Z Gastroenterol; 1983 Mar; 21 Suppl():33-40. PubMed ID: 6858409
[TBL] [Abstract][Full Text] [Related]
17. In vitro comparison of the antacid potencies of almagate in tablets and suspension with those of other commercially available antacid preparations.
Prieto R; Martinez-Tobed A; Fábregas JL; Beneyto JE
Arzneimittelforschung; 1984; 34(10A):1360-4. PubMed ID: 6548920
[TBL] [Abstract][Full Text] [Related]
18. Effects of a new effervescent cimetidine formulation on gastric acidity in healthy subjects.
Vlasblom V; Fellinger HW; Breumelhof R; Smout AJ
Neth J Med; 1991 Apr; 38(3-4):147-52. PubMed ID: 1881502
[TBL] [Abstract][Full Text] [Related]
19. [Steady intragastral pH measurement after application of antacid drugs (author's transl)].
Sommer H; Kasper H; Herzberger U
Med Klin; 1973 Nov; 68(46):1500-3. PubMed ID: 4782868
[No Abstract] [Full Text] [Related]
20. Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.
Krishna G; Kisicki JC; Olsen S; Grasela DM; Wang Z
Pharmacotherapy; 2007 Jul; 27(7):963-9. PubMed ID: 17594201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
